Convidecia single-dose vaccine approved for use as booster

Convidecia single-dose vaccine approved for use as booster

The health ministry says those who took the Sinovac or CanSino Bio primary dose could take the Convidecia as a booster.

The health ministry says Convidecia single-dose vaccine has been approved for use as a booster dose.
KUALA LUMPUR:
The Convidecia single-dose Covid-19 vaccine produced by CanSino has been approved for use as a booster.

The health ministry said applications for the CanSino-type booster dose would be available on the MySejahtera app soon.

Those who took the Sinovac or CanSino Bio vaccines as the primary dose could take the Convidecia vaccine as a booster dose within three months of the primary dose, the ministry said.

Stay current - Follow FMT on WhatsApp, Google news and Telegram

Subscribe to our newsletter and get news delivered to your mailbox.